Fondamentali 4111
CHI SHENG PHARMA & BIOTECH CO LTD panoramica sulla ripartizione dei ricavi
Il maggior contributo alle entrate proviene da Taiwan, da cui CHI SHENG PHARMA & BIOTECH CO LTD ha incassato 1.15 B TWD nell'ultimo anno, e 1.05 B TWD nell'anno precedente.
Per fonte
2017
2018
2019
2020
2021
2022
2023
2024
0,00
300,00 M
600,00 M
900,00 M
1,20 B
Western Medicines, Cosmetics, Health Foods, Medical Devices and Animal Medicines
Processing
Product Development
Injection
OEM and Others
Oral Preparation
External Use
Medical Equipment
Valuta: TWD
2017
2018
2019
2020
2021
2022
2023
2024
Western Medicines, Cosmetics, Health Foods, Medical Devices and Animal Medicines
—
—
—
—
925,68 M
Processing
—
—
—
—
234,93 M
Product Development
—
—
—
—
4,82 M
Injection
520,35 M
572,04 M
592,31 M
630,54 M
—
OEM and Others
344,09 M
346,44 M
392,36 M
290,36 M
—
Oral Preparation
38,21 M
50,58 M
85,32 M
67,31 M
—
External Use
37,23 M
36,31 M
36,68 M
36,92 M
—
Medical Equipment
39,48 M
36,44 M
36,41 M
35,74 M
—
Per paese
2017
2018
2019
2020
2021
2022
2023
2024
0,00
300,00 M
600,00 M
900,00 M
1,20 B
Taiwan
Other
China
Valuta: TWD
2017
2018
2019
2020
2021
2022
2023
2024
Taiwan
956,98 M
1,01 B
1,13 B
1,05 B
1,15 B
Other
8,32 M
8,36 M
9,56 M
10,85 M
12,33 M
China
14,06 M
19,51 M
—
—
—